Nexalin Technology Inc. (NXL) — Research Summary as of August 14, 2026

Company Overview

Nexalin Technology is a small-cap medical device company headquartered in Houston, TX, focused on non-invasive neurostimulation. Its proprietary platform is built around Deep Intracranial Frequency Stimulation (DIFS™) technology, with devices including the HALO™ Clarity and NeuroCare®, targeting indications such as insomnia, anxiety, depression, Alzheimer's disease/dementia, TBI/PTSD, and ADHD [11]. The company trades on Nasdaq under the ticker NXL, with a market cap of approximately $8 million and a recent share price around $0.34 [15][5].

---

Key Recent Catalysts (Last ~1–3 Months)